MedPharm is continually looking for opportunities to develop new formulation and drug delivery systems and technologies. These endeavour to enhance clients’ products, provide clinical benefits for patients and meet the increasingly stringent requirements of regulatory authorities. MedPharm has a track record of helping clients incorporate formulation intellectual property for client’s specific drugs as part of product life cycle management.
MedSpray is a patented formulation technology based on the ‘patch-in-a-can’ concept specifically developed by MedPharm for a range of applications. It leaves a film on the skin or another tissue surface and is thermodynamically optimised to maximise the permeation and penetration of the API through the tissue, making this a great alternative to drug delivery patches. This benefits patients by offering the long-term dosing of a product from a clear ‘patch’ that is conveniently applied as a spray from a can.
MedPharm has clinically demonstrated the efficacy of MedSpray and its applicability in a wide variety of treatments, including curing infections or pain management.
The unique dosing of MedSpray offers clients the opportunity to differentiate their product through its ease of use and enhanced delivery with the potential to achieve premium pricing for extended effects.